Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

BCR/ABL signal transduction

T Tauchi1, H E Broxmeyer

  • 1Department of Medicine (Hematology/Oncology), Indiana University School of Medicine, Indianapolis 46202-5121, USA.

International Journal of Hematology
|April 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

DPP4 truncated GM-CSF and IL-3 manifest distinct receptor-binding and regulatory functions compared with their full-length forms.

Leukemia·2017
Same author

Small-molecule inhibitors targeting the DNA-binding domain of STAT3 suppress tumor growth, metastasis and STAT3 target gene expression in vivo.

Oncogene·2016
Same author

Activation of OCT4 enhances ex vivo expansion of human cord blood hematopoietic stem and progenitor cells by regulating HOXB4 expression.

Leukemia·2015
Same author

Small-molecule inhibitors targeting the DNA-binding domain of STAT3 suppress tumor growth, metastasis and STAT3 target gene expression in vivo.

Oncogene·2015
Same author

Insights into the biology of cord blood stem/progenitor cells.

Cell proliferation·2011
Same author

Experimental basis of cord blood transplantation.

Bone marrow transplantation·2009
Same journal

Allogeneic hematopoietic cell transplantation with reduced-toxicity conditioning for X-linked hyper-IgM syndrome.

International journal of hematology·2026
Same journal

Incidence, etiology, and predictors of early mortality after induction chemotherapy for aml in a middle-income country.

International journal of hematology·2026
Same journal

Modified short-course fludarabine-based conditioning regimen for salvage cord blood transplantation after graft failure.

International journal of hematology·2026
Same journal

Cytarabine-based induction and oral maintenance therapy for a single system with single-site Langerhans cell histiocytosis.

International journal of hematology·2026
Same journal

Long-term treatment-free remission in CML after early dasatinib discontinuation due to interstitial pneumonitis.

International journal of hematology·2026
Same journal

Correction to: Low reticulocyte count at infusion is a risk factor for high-grade cytokine release syndrome in chimeric antigen receptor T cell therapy.

International journal of hematology·2026
See all related articles

The Philadelphia chromosome (Ph1) is strongly linked to chronic myelogenous leukemia (CML) pathogenesis. This review details intracellular signaling involving BCR/ABL fusion genes in Ph1-positive human leukemia.

Area of Science:

  • Oncology
  • Molecular Biology
  • Hematology

Background:

  • The Philadelphia chromosome (Ph1) is a hallmark genetic abnormality in chronic myelogenous leukemia (CML).
  • Ph1-positive leukemias are extensively studied for their molecular, clinical, and cell biological aspects.
  • Understanding the role of Ph1 is crucial for CML pathogenesis research.

Purpose of the Study:

  • To review intracellular signaling pathways regulated by BCR/ABL fusion gene products.
  • To elucidate the role of the Ph1 chromosome in the development of human leukemia.
  • To provide a molecular perspective on Ph1-positive leukemias.

Main Methods:

  • Literature review of studies on Ph1-positive leukemias.
  • Analysis of molecular mechanisms involving BCR/ABL fusion proteins.

Related Experiment Videos

  • Synthesis of data from clinical and cell biological research.

    • Main Results:

    • The BCR/ABL fusion gene product is a constitutively active tyrosine kinase.
    • BCR/ABL signaling pathways are critical for CML cell proliferation and survival.
    • Aberrant signaling contributes significantly to the pathogenesis of Ph1-positive leukemia.

    Conclusions:

    • The Ph1 translocation and resulting BCR/ABL oncoprotein are central to CML.
    • Intracellular signaling events mediated by BCR/ABL are key drivers of leukemogenesis.
    • Targeting BCR/ABL signaling pathways offers therapeutic strategies for CML.